AI assistant
NEOGENOMICS INC — Director's Dealing 2017
May 30, 2017
32227_dirs_2017-05-30_ab8f25dd-89b7-4f25-9479-8b5ef8a04439.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-05-25
Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-26 | Common Stock | S | 3334 | $7.50 | Disposed | 10049 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-25 | Restricted Stock | $0.00 | A | 20000 | Acquired | Common Stock (20000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.76 | 2018-04-16 | Common Stock (7500) | 7500 | Direct |
| Stock Option (Right to Buy) | $3.45 | 2019-03-05 | Common Stock (15000) | 15000 | Direct |
| Stock Option (Right to Buy) | $4.78 | 2020-05-04 | Common Stock (120000) | 120000 | Direct |
| Stock Option (Right to Buy) | $7.15 | 2021-04-20 | Common Stock (50000) | 50000 | Direct |
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (60000) | 60000 | Direct |
Footnotes
F1: On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F2: On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F3: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F4: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.
F6: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F7: Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.
F8: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.